Cellecta - HT RNAi Screens, Pooled Lentiviral shRNA Libraries Cellecta develops advanced high-throughput RNAi technologies and applications for the discovery and functional characterization of novel therapeutic targets and drugs. Our contract and collaborative research includes performing HT RNAi and peptide genetic screens, constructing pooled lentiviral shRNA and peptide libraries, and developing stable overexpression, knockdown, or reporter cell lines. Cellecta.com~Site InfoWhoisTrace RouteRBL Check